Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
Clinical trial NCT05536973 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05536973
- Sponsor
- Adverum Biotechnologies, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2024-08-26
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.